ad image

Q32021

1 / 2
Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?
Social Media Marketing

Q: What’s the next “big thing” on the horizon that will significantly alter the pharma/biopharma market, your operations, or the way you do business?

Pharma's Almanac

PA741Oct 11, 2021
Q: What do you think most differentiates the U.S. pharma/biopharma industry or the market?
Evolving Technologies

Q: What do you think most differentiates the U.S. pharma/biopharma industry or the market?

Pharma's Almanac

PA742Oct 11, 2021
Navigating Analytical Requirements for GMP Viral Vectors
Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

Will Fountain

Andelyn Biosciences

PAO-10-21-CL-02Oct 08, 2021
Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing
Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

Wade Macedone; Jonathan Rush; Phillip Vermilion; Samir Acharya, Ph.D.

Andelyn Biosciences

PAO-10-21-CL-01Oct 07, 2021
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis
Cell Therapy

Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis

Ashish Patel, Ph.D.

The National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC)

PAO-09-21-CL-13Sep 29, 2021
Pandemic Playbook for Gene Therapy Manufacturing
Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.

MilliporeSigma

PAO-09-21-CL-14Sep 29, 2021
Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives
Live Biotherapeutic Products

Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives

Aaron B. Cowley, Ph.D.; Nicole O'Brien, Ph.D.

ReciBioPharm

PAO-09-21-CL-11Sep 28, 2021
Lean and Client-Focused: The Future of Life Sciences Engineering and Architecture
Engineering

Lean and Client-Focused: The Future of Life Sciences Engineering and Architecture

Aidan O'Dwyer

PAO-09-21-CL-12Sep 28, 2021
Expanding and Serving the Market with Flexible Single-Use Capacity
Facility Expansion

Expanding and Serving the Market with Flexible Single-Use Capacity

Michael Alston, Jr.

Avid Bioservices

PAO-09-21-CL-09Sep 17, 2021
Designing More Sustainable Small Molecule API Manufacturing Processes
Process Development

Designing More Sustainable Small Molecule API Manufacturing Processes

Marko Salo; Arne Grumann

Fermion

PAO-09-21-CL-05Sep 16, 2021
Integrating a Personal Approach to Clinical Supply Services
Clinical Supply

Integrating a Personal Approach to Clinical Supply Services

Alexander Fetkovsky

SanaClis

PAO-09-21-CL-08Sep 14, 2021
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
Tablet Coating

An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility

Thomas Kipping, Ph.D.

MilliporeSigma

PAO-09-21-CL-06Sep 14, 2021
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

PAO-09-21-CL-07Sep 14, 2021
Solving the Patient-Centric Formulation Riddle

Solving the Patient-Centric Formulation Riddle

Beau Garrett

Tapemark

PA806Sep 09, 2021
Critical Cleaning and Detergent Synergy
Critical Cleaning

Critical Cleaning and Detergent Synergy

Michael Moussourakis

Alconox Inc.

PAO-08-21-CL-07Sep 09, 2021
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Cell Therapy

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

Chris McClain

Be The Match BioTherapies

PAO-09-21-CL-04Sep 09, 2021
For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record
Biotech-CDMO Relationship

For mAbs, a Small Biotech Recognizes the Value in Lonza’s Expertise and Track Record

William Ben Jones, Ph.D.

Corvus Pharmaceuticals

PAO-09-21-CL-03Sep 08, 2021
Enabling 4D Proteomics and Epiproteomics

Enabling 4D Proteomics and Epiproteomics

Rohan Thakur, Ph.D.

PA816Sep 08, 2021
What to Look for When Choosing the Right CDMO
Customer Centricity

What to Look for When Choosing the Right CDMO

Jeremy Tatum; Michael Kays

TriRx Pharmaceutical Services

PAO-09-21-CL-02Sep 08, 2021
Integrating Heterogeneous Data to Enable Precision Medicine
Data Integration

Integrating Heterogeneous Data to Enable Precision Medicine

Marilyn Matz; Zachary Pitluk, Ph.D.

Paradigm4

PA819Sep 01, 2021
1 / 2